Drug reference
rimonabant
synthetic CB receptor antagonist
synthetic CB receptor antagonist
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
Smoking cessation (modest improvement in abstinence rate)
Contraindications
- Approved for use in the U.S.
Side effects
Serious
- Depressive symptoms
- Neurological symptoms
Related guidelines
Ask House about rimonabant
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team